Joe Biden begins treatment for aggressive prostate cancer
- Joe Biden has begun undergoing radiation therapy and hormone treatment for an aggressive form of prostate cancer.
- The cancer was diagnosed in May 2025 after issues with his urinary system led to further examination.
- Despite diagnosis of incurable cancer, advancements in treatment provide hope for extending life expectancy.
In October 2025, Joe Biden, the former President of the United States, has commenced a significant treatment plan for aggressive prostate cancer. The treatment includes radiation therapy alongside hormone therapy, as confirmed by a spokesperson. Biden, aged 82, initially revealed his cancer diagnosis in May 2025, indicating that the disease had already metastasized to his bones. This form of cancer has a high Gleason score of 9, which signifies its aggressive nature and places it in the most severe risk category. His medical team is hopeful, citing advancements in hormonal medication that may extend his life despite the incurable nature of the condition. Biden’s prostate cancer story began following concerns regarding his urinary system, leading to the discovery of a small nodule on his prostate. Medical examinations subsequently confirmed it was an aggressive cancer. Dr. Benjamin Davies, a urologic oncology expert, emphasized that while the cancer is considered incurable due to its spread, treatments could significantly improve the prognosis. In May, Biden expressed optimism about beating the illness, stating that it had not invaded any organs or penetrated his bones. In addition to his current prostate cancer treatment, Biden had recently undergone Mohs surgery to remove skin cancer lesions. The former president suffered from basal cell carcinoma, a common form of skin cancer, which was surgically addressed. His approach to battling cancer reflects his broader commitment to cancer research, highlighted during his presidency by launching the cancer moonshot initiative aimed at improving cancer treatment and diagnosis. Biden has been receiving his treatments in Philadelphia, where he is closely monitored. According to reports from individuals familiar with his situation, he is responding well to the prescribed treatments. The public has shown a keen interest in Biden’s health, noting that prostate cancer is the second-most common cancer among men and that age significantly impacts risk factors. His cancer journey underscores the importance of regular health screenings, especially for older adults. As medical advancements continue, Biden's case serves as a critical reminder of the ongoing battle against cancer and the hope that newer therapies bring to those affected by it.